Meet with…CPRIT

Add this event to your calendar:
07/02/2018 11:30 07/02/2018 14:00 America/Chicago Meet with…CPRIT JLABS @ TMC , John P. McGovern Campus , Houston , TX 77021 JLABS @ TMC false DD/MM/YYYY
February
7
Event

Meet with…CPRIT

JLABS @ TMC , John P. McGovern Campus , Houston , TX 77021

February 07, 2018 from 11:30 AM to 14:00 PM (CDT)

$10 - $35


Since 2009, CPRIT has awarded more than $1.35 billion in grants to Texas researchers, institutions and organizations. CPRIT provides funding through its academic research, prevention and product development research programs. Programs made possible with CPRIT funding have reached all 254 counties of the state, brought nearly 100 distinguished researchers to Texas, advanced scientific and clinical knowledge, and provided more than 2.5 million life-saving education, training, prevention and early detection services to Texans.

Following an overview of CPRIT's funding opportunities and key areas of interest, don't miss the opportunity to introduce yourself during the networking lunch. And finally, for those companies who apply online and are approved, one-on-one meetings with CPRIT will provide a forum to further discuss your company.


Agenda:
10:30am | Registration Opens and Networking
11:00am | Presentation and Q&A
11:45am | Networking Lunch
1:00-5:00pm | One-on-one Meetings*

*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ends on January 24th, 2018.


CPRIT Participating Representative:Michael Lang | Chief Product Development Research Officer, CPRIT 
Mike Lang leads CPRIT's product development research program, designed to accelerate the progression of new cancer drugs, diagnostics, and therapies from the laboratory into clinical practice. His multi-state experience includes founding and serving as chief executive officer of a cancer diagnostic company, serial entrepreneurship, and managing a portfolio for an early stage investment. Prior to joining CPRIT in November 2015, Lang was the founder and CEO of NanoVision, a cancer diagnostics company. He headed business development at the venture capital-funded wound healing company Gilatech, where he led its novel biomaterial therapy. Lang oversaw a company restructuring as president of Dallas-based Galt Medical, served as a product manager at Johnson & Johnson, and was vice president of business development at BioEnterprise, where he directed the startup and growth of early stage firms. Lang has a bachelor's in biomedical engineering from Northern Arizona University and a master's in business administration from Arizona State University.
Connect with CPRIT: Like on Facebook Follow on Twitter


Fees:
Presentation & Lunch
$25 | General Public
$35 | General Public Onsite
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Registration to attend the presentation, Q&A, and lunch will remain open until noon on February 6th, 2018 (or sold out).

One-on-One Meeting
FREE | Application
FREE | Accepted Companies
Companies must have applied for a one-on-one meeting ahead of time. The one-on-one application period ends on January 24th, 2018. Your application will be reviewed and you will be notified of acceptance by email. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved.


About the Meet with... Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Canaan Partners, Thomas McNerney & Partners, NCI, NCATS, NINDS, Allegory Venture Partners, Clarus Ventures, Johnson & Johnson Innovation, Poliwogg, California Institute for Regenerative Medicine, Astellas Venture Management, and OrbiMed.


Location:
JLABS @ TMC
John P. McGovern Campus
2450 Holcombe Blvd, Suite J
Houston, TX 77021


Parking Information:
Please park in the self parking areas of the McGovern Campus. Grab a Token at the gate and bring it to the event space. We encourage carpooling and using the TMC shuttles.
TMC Map


JLABS @ TMC

Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and digital health sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to eight locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto and a ninth location, New York City, launching in 2018. For more information please visit jlabs.jnjinnovation.com.

Event contact


Related content